Rodriguez, C.A., Natukunda, E., Strehlau, R., Venter, E.L., Rungmaitree, S., Cunningham, C.K., Lalloo, U., Kosalaraksa, P., HellstrÖm, E., Liberty, A. and McGrath, E.J., 2024. Pharmacokinetics and safety of coformulated bictegravir, emtricitabine, and tenofovir alafenamide in children aged 2 years and older with virologically suppressed HIV: a phase 2/3, open-label, single-arm study. The Lancet HIV, 11(5), pp.e300-e308.
Pharmacokinetics and safety of coformulated bictegravir, emtricitabine, and tenofovir alafenamide in children aged 2 years and older with virologically suppressed HIV: a phase 2/3, open-label, single-arm study.
- Journal Articles
